{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T10:05:33Z","timestamp":1789553133780,"version":"build-2803163510"},"reference-count":133,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T00:00:00Z","timestamp":1685491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Survival in patients with hematological malignancies has improved over the years, both due to major developments in anticancer treatment, as well as in supportive care. Nevertheless, important and debilitating complications of intensive treatment regimens still frequently occur, including mucositis, fever and bloodstream infections. Exploring potential interacting mechanisms and directed therapies to counteract mucosal barrier injury is of the utmost importance if we are to continue to improve care for this increasingly growing patient population. In this perspective, I highlight recent advances in our understanding of the relation of mucositis and infection.<\/jats:p>","DOI":"10.3390\/ijms24119592","type":"journal-article","created":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T03:06:00Z","timestamp":1685588760000},"page":"9592","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Mucositis and Infection in Hematology Patients"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1801-2072","authenticated-orcid":false,"given":"Nicole M. A.","family":"Blijlevens","sequence":"first","affiliation":[{"name":"Department of Haematology, Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3210-2215","authenticated-orcid":false,"given":"Charlotte E. M.","family":"de Mooij","sequence":"additional","affiliation":[{"name":"Department of Haematology, Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,5,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e662","DOI":"10.1097\/HS9.0000000000000662","article-title":"The EHA Research Roadmap: Infections in Hematology","volume":"5","author":"Cordonnier","year":"2021","journal-title":"Hemasphere"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1200\/JCO.18.00374","article-title":"Antimicrobial Prophylaxis for Adult Patients with Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update","volume":"36","author":"Taplitz","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1007\/s40121-022-00700-1","article-title":"The Dutch Working Party on Antibiotic Policy (SWAB) Recommendations for the Diagnosis and Management of Febrile Neutropenia in Patients with Cancer","volume":"11","author":"Bruns","year":"2022","journal-title":"Infect. Dis. Ther."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1200\/JCO.22.02224","article-title":"Guideline for the Management of Fever and Neutropenia in Pediatric Patients with Cancer and Hematopoietic Cell Transplantation Recipients: 2023 Update","volume":"41","author":"Lehrnbecher","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1002\/cncr.33100","article-title":"MASCC\/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy","volume":"126","author":"Elad","year":"2020","journal-title":"Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1007\/s00520-020-05803-4","article-title":"MASCC\/ISOO clinical practice guidelines for the management of mucositis: Sub-analysis of current interventions for the management of oral mucositis in pediatric cancer patients","volume":"29","author":"Zadik","year":"2021","journal-title":"Support. Care Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3322\/caac.21704","article-title":"The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies","volume":"72","author":"Elad","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1200\/JCO.2007.13.6028","article-title":"Prospective Oral Mucositis Audit: Oral Mucositis in Patients Receiving High-Dose Melphalan or BEAM Conditioning Chemotherapy\u2014European Blood and Marrow Transplantation Mucositis Advisory Group","volume":"26","author":"Blijlevens","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"114644","DOI":"10.1016\/j.biopha.2023.114644","article-title":"Review on the effect of chemotherapy on the intestinal barrier: Epithelial permeability, mucus and bacterial translocation","volume":"162","author":"Dahlgren","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1601-0825.2010.01681.x","article-title":"New thoughts on the initiation of mucositis","volume":"16","author":"Sonis","year":"2010","journal-title":"Oral Dis."},{"key":"ref_11","first-page":"lgz011","article-title":"Oral Mucositis Due to High-Dose Chemotherapy and\/or Head and Neck Radiation Therapy","volume":"2019","author":"Lalla","year":"2019","journal-title":"JNCI Monogr."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1097\/01.inf.0000095196.19606.d2","article-title":"Endotoxemia and elevation of lipopolysaccharide-binding protein after hematopoietic stem cell transplantation","volume":"22","author":"Levy","year":"2003","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ijc.11196","article-title":"Simultaneous onset of acute inflammatory response, sepsis-like symptoms and intestinal mucosal injury after cancer chemotherapy","volume":"107","author":"Tsuji","year":"2003","journal-title":"Int. J. Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature17039","article-title":"Faculty Opinions recommendation of Reparative inflammation takes charge of tissue regeneration","volume":"529","author":"Karin","year":"2016","journal-title":"Nature"},{"key":"ref_15","first-page":"lgz002","article-title":"Oral Microbiome and Cancer Therapy-Induced Oral Mucositis","volume":"2019","author":"Mougeot","year":"2019","journal-title":"JNCI Monogr."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/SPC.0000000000000053","article-title":"Can the oral microflora affect oral ulcerative mucositis?","volume":"8","author":"Laheij","year":"2014","journal-title":"Curr. Opin. Support. Palliat. Care"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev-immunol-030409-101311","article-title":"The Sterile Inflammatory Response","volume":"28","author":"Rock","year":"2010","journal-title":"Annu. Rev. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3390\/curroncol30010074","article-title":"Interventions for the Prevention of Oral Mucositis in Patients Receiving Cancer Treatment: Evidence from Randomised Controlled Trials","volume":"30","author":"Colella","year":"2023","journal-title":"Curr. Oncol."},{"key":"ref_19","first-page":"e378","article-title":"Double-blind, randomized pilot study of bioadhesive chlorhexidine gel in the prevention and treatment of mucositis induced by chemoradiotherapy of head and neck cancer","volume":"20","year":"2015","journal-title":"Med. Oral Patol. Oral Cir. Bucal."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/0030-4220(92)90009-F","article-title":"Efficacy of chlorhexidine and nystatin rinses in prevention of oral complications in leukemia and bone marrow transplantation","volume":"73","author":"Epstein","year":"1992","journal-title":"Oral Surg. Oral Med. Oral Pathol."},{"key":"ref_21","first-page":"921","article-title":"Randomized clinical trial of chlorhexidine versus placebo for prevention of oral mucositis in patients receiving chemotherapy","volume":"23","author":"Dodd","year":"1996","journal-title":"Oncol. Nurs. Forum"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/cncr.23328","article-title":"Double-blind, placebo-controlled, randomized study of chlorhexidine prophylaxis for 5-fluorouracil-based chemotherapy-induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy) in gastrointestinal malignancies","volume":"112","author":"Sorensen","year":"2008","journal-title":"Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1016\/S0959-8049(01)00098-3","article-title":"Evaluation of an oral care protocol intervention in the prevention of chemotherapy-induced oral mucositis in paediatric cancer patients","volume":"37","author":"Cheng","year":"2001","journal-title":"Eur. J. Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1054\/ejon.2001.0161","article-title":"An oral care protocol intervention to prevent chemotherapy-induced oral mucositis in paediatric cancer patients: A pilot study","volume":"6","author":"Cheng","year":"2002","journal-title":"Eur. J. Oncol. Nurs."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1080\/1042819031000079159","article-title":"A Phase III, Randomized, Double-blind, Placebo-controlled, Multinational Trial of Iseganan for the Prevention of Oral Mucositis in Patients Receiving Stomatotoxic Chemotherapy (PROMPT-CT Trial)","volume":"44","author":"Giles","year":"2003","journal-title":"Leuk. Lymphoma"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00520-021-06409-0","article-title":"Azithromycin oral suspension in prevention and management of oral mucositis in patients undergoing hematopoietic stem cell transplantation: A randomized controlled trial","volume":"30","author":"Parkhideh","year":"2022","journal-title":"Support. Care Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s00520-005-0792-9","article-title":"The comparative effects of povidone-iodine and normal saline mouthwashes on oral mucositis in patients after high-dose chemotherapy and APBSCT\u2014Results of a randomized multicentre study","volume":"13","author":"Vokurka","year":"2005","journal-title":"Support. Care Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1473-3099(03)00668-6","article-title":"Antimicrobial therapy to prevent or treat oral mucositis","volume":"3","author":"Donnelly","year":"2003","journal-title":"Lancet Infect. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/s41579-022-00768-z","article-title":"Microbiota succession throughout life from the cradle to the grave","volume":"20","author":"Martino","year":"2022","journal-title":"Nat. Rev. Genet."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/1471-2180-9-259","article-title":"Defining the healthy \u201ccore microbiome\u201d of oral microbial communities","volume":"9","author":"Zaura","year":"2009","journal-title":"BMC Microbiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"16929","DOI":"10.1038\/s41598-019-53073-w","article-title":"Microbial changes in relation to oral mucositis in autologous hematopoietic stem cell transplantation recipients","volume":"9","author":"Laheij","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"17527","DOI":"10.1038\/s41598-022-21775-3","article-title":"Commensal oral microbiota impacts ulcerative oral mucositis clinical course in allogeneic stem cell transplant recipients","volume":"12","author":"Bruno","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"154532","DOI":"10.1155\/2013\/154532","article-title":"The Influence of Oral Bacteria on Epithelial Cell Migration In Vitro","volume":"2013","author":"Laheij","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nature11550","article-title":"Faculty Opinions recommendation of Diversity, stability and resilience of the human gut microbiota","volume":"489","author":"Lozupone","year":"2012","journal-title":"Nature"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nrmicro2974","article-title":"The gut microbiota\u2014Masters of host development and physiology","volume":"11","author":"Sommer","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1126\/science.1223490","article-title":"Interactions Between the Microbiota and the Immune System","volume":"336","author":"Hooper","year":"2012","journal-title":"Science"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1002\/cncr.32641","article-title":"Gut dysbiosis during antileukemia chemotherapy versus allogeneic hematopoietic cell transplantation","volume":"126","author":"Rashidi","year":"2020","journal-title":"Cancer"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/cid\/ciz777","article-title":"Gut Microbiome Signatures Are Predictive of Infectious Risk Following Induction Therapy for Acute Myeloid Leukemia","volume":"71","author":"Shi","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/cid\/ciy153","article-title":"Gut Microbiome Composition Predicts Infection Risk During Chemotherapy in Children with Acute Lymphoblastic Leukemia","volume":"67","author":"Hakim","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1056\/NEJMoa1900623","article-title":"Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation","volume":"382","author":"Peled","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1966262","DOI":"10.1080\/19490976.2021.1966262","article-title":"The emerging roles of the gut microbiome in allogeneic hematopoietic stem cell transplantation","volume":"13","author":"Khuat","year":"2021","journal-title":"Gut Microbes"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"McMahon, S., Sahasrabhojane, P., Kim, J., Franklin, S., Chang, C.C., Jenq, R.R., Hillhouse, A.E., Shelburne, S.A., and Galloway-Pe\u00f1a, J. (2023). Contribution of the Oral and Gastrointestinal Microbiomes to Bloodstream Infections in Leukemia Patients. Microbiol. Spectr., e0041523.","DOI":"10.1128\/spectrum.00415-23"},{"key":"ref_43","first-page":"2978","article-title":"Impact of gut colonization with butyrate producing microbiota on respiratory viral infection following allo-HCT","volume":"131","author":"Haak","year":"2018","journal-title":"Blood"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1084\/jem.20112408","article-title":"Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation","volume":"209","author":"Jenq","year":"2012","journal-title":"J. Exp. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1182\/blood-2016-09-691394","article-title":"The intestinal microbiota in allogeneic hematopoietic cell transplant and graft-versus-host disease","volume":"129","author":"Staffas","year":"2017","journal-title":"Blood"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrc.2018.10","article-title":"Gut microbiota injury in allogeneic haematopoietic stem cell transplantation","volume":"18","author":"Shono","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1200\/JCO.2016.70.3348","article-title":"Intestinal Microbiota and Relapse After Hematopoietic-Cell Transplantation","volume":"35","author":"Peled","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1016\/j.bbmt.2018.06.031","article-title":"Impact of the Use and Type of Antibiotics on Acute Graft-versus-Host Disease","volume":"24","author":"Nishi","year":"2018","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/j.bbmt.2019.06.001","article-title":"Alteration of the Intestinal Microbiota by Broad-Spectrum Antibiotic Use Correlates with the Occurrence of Intestinal Graft-versus-Host Disease","volume":"25","author":"Lee","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"eaap9489","DOI":"10.1126\/scitranslmed.aap9489","article-title":"Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant","volume":"10","author":"Taur","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.bbmt.2017.02.006","article-title":"Microbiota Disruption Induced by Early Use of Broad-Spectrum Antibiotics Is an Independent Risk Factor of Outcome after Allogeneic Stem Cell Transplantation","volume":"23","author":"Weber","year":"2017","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/cid\/ciy711","article-title":"Detrimental Effect of Broad-spectrum Antibiotics on Intestinal Microbiome Diversity in Patients After Allogeneic Stem Cell Transplantation: Lack of Commensal Sparing Antibiotics","volume":"68","author":"Weber","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"339ra71","DOI":"10.1126\/scitranslmed.aaf2311","article-title":"Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice","volume":"8","author":"Shono","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1126\/science.aax3760","article-title":"Lactose drives Enterococcus expansion to promote graft-versus-host disease","volume":"366","author":"Nichols","year":"2019","journal-title":"Science"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"eaay9097","DOI":"10.1126\/science.aay9097","article-title":"Multi-omics analyses of radiation survivors identify radioprotective microbes and metabolites","volume":"370","author":"Guo","year":"2020","journal-title":"Science"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/apt.13302","article-title":"Chemotherapy-driven dysbiosis in the intestinal microbiome","volume":"42","author":"Montassier","year":"2015","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"282356","DOI":"10.1155\/2011\/282356","article-title":"Identification of NF-kappaB modulation capabilities within human intestinal commensal bacteria","volume":"2011","author":"Lakhdari","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1348-0421.2011.00398.x","article-title":"Anti-inflammatory properties of intestinal Bifidobacterium strains isolated from healthy infants","volume":"56","author":"Khokhlova","year":"2012","journal-title":"Microbiol. Immunol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/cid\/ciab500","article-title":"Prolonged Suppression of Butyrate-Producing Bacteria Is Associated with Acute Gastrointestinal Graft-vs-Host Disease and Transplantation-Related Mortality After Allogeneic Stem Cell Transplantation","volume":"74","author":"Meedt","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1136\/gutjnl-2020-322260","article-title":"Mucus barrier, mucins and gut microbiota: The expected slimy partners?","volume":"69","author":"Paone","year":"2020","journal-title":"Gut"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1800897","DOI":"10.1080\/19490976.2020.1800897","article-title":"Impact and consequences of intensive chemotherapy on intestinal barrier and microbiota in acute myeloid leukemia: The role of mucosal strengthening","volume":"12","author":"Hueso","year":"2020","journal-title":"Gut Microbes"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/ijc.32942","article-title":"Gastrointestinal toxicity during induction treatment for childhood acute lymphoblastic leukemia: The impact of the gut microbiota","volume":"147","author":"Ingham","year":"2020","journal-title":"Int. J. Cancer"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2181922","DOI":"10.1080\/19490976.2023.2181922","article-title":"The emerging roles of bacterial proteases in intestinal diseases","volume":"15","author":"Caminero","year":"2023","journal-title":"Gut Microbes"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3748\/wjg.v24.i1.5","article-title":"Relationship between intestinal microbiota and ulcerative colitis: Mechanisms and clinical application of probiotics and fecal microbiota transplantation","volume":"24","author":"Shen","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/s41579-019-0256-8","article-title":"Diet\u2013microbiota interactions and personalized nutrition","volume":"17","author":"Kolodziejczyk","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00280-021-04273-7","article-title":"Translational model of melphalan-induced gut toxicity reveals drug-host-microbe interactions that drive tissue injury and fever","volume":"88","author":"Wardill","year":"2021","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1093\/annonc\/mdp596","article-title":"Citrulline-based assessment score: First choice for measuring and monitoring intestinal failure after high-dose chemotherapy","volume":"21","author":"Herbers","year":"2010","journal-title":"Ann. Oncol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1093\/cid\/ciac299","article-title":"Protective Effect of Intestinal Blautia Against Neutropenic Fever in Allogeneic Transplant Recipients","volume":"75","author":"Rashidi","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/bjh.13113","article-title":"Mucosal barrier injury, fever and infection in neutropenic patients with cancer: Introducing the paradigm febrile mucositis","volume":"167","author":"Herbers","year":"2014","journal-title":"Br. J. Haematol."},{"key":"ref_70","first-page":"1152","article-title":"Blautia Abundance and Mucosal Barrier Injury: A Complex Play of Cause and Effect","volume":"76","author":"Molendijk","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1158\/1078-0432.CCR-22-1254","article-title":"Conditioning Regimens are Associated with Distinct Patterns of Microbiota Injury in Allogeneic Hematopoietic Cell Transplantation","volume":"29","author":"Shouval","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"ref_72","unstructured":"Wardill, H.v.G.L., Molendijk, E., Ferreira Da Silva, A.R., Kurilshikov, A., Dorraki, M., Ryan, F., Harmsen, H., Tissing, W., van der Velden, W., and Blijlevens, N. (2023). Unravelling the factors that shape gut dysbiosis in AHCT recipients, Submitted manuscript."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"103289","DOI":"10.1016\/j.critrevonc.2021.103289","article-title":"Recent insights into the role of the microbiome in malignant and benign hematologic diseases","volume":"160","author":"Fattizzo","year":"2021","journal-title":"Crit. Rev. Oncol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/s41409-018-0401-4","article-title":"Bacterial blood stream infections (BSIs), particularly post-engraftment BSIs, are associated with increased mortality after allogeneic hematopoietic cell transplantation","volume":"54","author":"Ustun","year":"2018","journal-title":"Bone Marrow Transplant."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"798.e1","DOI":"10.1016\/j.jtct.2021.05.028","article-title":"Infection-Related Mortality in Adults and Children Undergoing Allogeneic Hematopoietic Cell Transplantation: An Australian Registry Report","volume":"27","author":"Lindsay","year":"2021","journal-title":"Transplant. Cell. Ther."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1469-0691.2005.01240.x","article-title":"Management of the febrile neutropenic cancer patient: Lessons from 40 years of study","volume":"11","author":"Bow","year":"2005","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.3324\/haematol.2013.091025","article-title":"European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: Summary of the 2011 4th European Conference on Infections in Leukemia","volume":"98","author":"Averbuch","year":"2013","journal-title":"Haematologica"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1473-3099(08)70284-6","article-title":"Infection-control interventions for cancer patients after chemotherapy: A systematic review and meta-analysis","volume":"9","author":"Schlesinger","year":"2009","journal-title":"Lancet Infect. Dis."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jinf.2017.10.009","article-title":"Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines","volume":"76","author":"Mikulska","year":"2018","journal-title":"J. Infect."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1086\/671281","article-title":"Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infection: Results from a Field Test of a New National Healthcare Safety Network Definition","volume":"34","author":"See","year":"2013","journal-title":"Infect. Control. Hosp. Epidemiol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.ajic.2016.03.011","article-title":"A clinical practical approach to the surveillance definition of central line\u2013associated bloodstream infection in cancer patients with mucosal barrier injury","volume":"44","author":"Chaftari","year":"2016","journal-title":"Am. J. Infect. Control"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jiac.2017.08.013","article-title":"Impact of mucosal barrier injury laboratory-confirmed bloodstream infection (MBI-LCBI) on central line-associated bloodstream infections (CLABSIs) in department of hematology at single university hospital in Japan","volume":"24","author":"Kato","year":"2018","journal-title":"J. Infect. Chemother."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1017\/ice.2014.38","article-title":"The Burden of Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infection among Hematology, Oncology, and Stem Cell Transplant Patients","volume":"36","author":"Metzger","year":"2015","journal-title":"Infect. Control. Hosp. Epidemiol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"e1918668","DOI":"10.1001\/jamanetworkopen.2019.18668","article-title":"Incidence, Risk Factors, and Outcomes of Patients Who Develop Mucosal Barrier Injury\u2013Laboratory Confirmed Bloodstream Infections in the First 100 Days After Allogeneic Hematopoietic Stem Cell Transplant","volume":"3","author":"Dandoy","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.bbmt.2016.06.002","article-title":"Healthcare Burden, Risk Factors, and Outcomes of Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections after Stem Cell Transplantation","volume":"22","author":"Dandoy","year":"2016","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/s41409-022-01719-1","article-title":"Grading bloodstream infection risk using citrulline as a biomarker of intestinal mucositis in patients receiving intensive therapy","volume":"57","author":"Fazel","year":"2022","journal-title":"Bone Marrow Transplant."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"van der Velden, W.J., Herbers, A.H., Feuth, T., Schaap, N.P., Donnelly, J.P., and Blijlevens, N.M. (2010). Intestinal damage determines the inflammatory response and early complications in patients receiving conditioning for a stem cell transplantation. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0015156"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/bmt.2008.313","article-title":"Fewer infections and lower infection-related mortality following non-myeloablative versus myeloablative conditioning for allotransplantation of patients with lymphoma","volume":"43","author":"Bachanova","year":"2009","journal-title":"Bone Marrow Transplant."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s00432-022-03995-2","article-title":"Impact of treatment intensity on infectious complications in patients with acute myeloid leukemia","volume":"149","author":"Tober","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/sj.bmt.1705686","article-title":"A randomized comparison of empiric or pre-emptive antibiotic therapy after hematopoietic stem cell transplantation","volume":"40","author":"Slavin","year":"2007","journal-title":"Bone Marrow Transplant."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1093\/annonc\/mdu035","article-title":"Prophylaxis of infectious complications with colony-stimulating factors in adult cancer patients undergoing chemotherapy\u2014Evidence-based guidelines from the Infectious Diseases Working Party AGIHO of the German Society for Haematology and Medical Oncology (DGHO)","volume":"25","author":"Vehreschild","year":"2014","journal-title":"Ann. Oncol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/bmt.2013.172","article-title":"Incidence of and risk factors for persistent gram-positive bacteraemia and catheter-related thrombosis in haematopoietic stem cell transplantation","volume":"49","author":"Richters","year":"2014","journal-title":"Bone Marrow Transplant."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1001\/archinternmed.2011.374","article-title":"Italy for the Hema e-Chart Group Etiology of Febrile Episodes in Patients with Acute Myeloid Leukemia: Results from the Hema e-Chart Registry","volume":"171","author":"Pagano","year":"2011","journal-title":"Arch. Intern. Med."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1200\/JCO.2013.51.6963","article-title":"Results of a Multicenter, Controlled, Randomized Clinical Trial Evaluating the Combination of Piperacillin\/Tazobactam and Tigecycline in High-Risk Hematologic Patients with Cancer with Febrile Neutropenia","volume":"32","author":"Bucaneve","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Ziegler, I., Lindstr\u00f6m, S., K\u00e4llgren, M., Str\u00e5lin, K., and M\u00f6lling, P. (2019). 16S rDNA droplet digital PCR for monitoring bacterial DNAemia in bloodstream infections. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0224656"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"e573","DOI":"10.1016\/S2352-3026(22)00166-1","article-title":"[(18)F]FDG-PET-CT compared with CT for persistent or recurrent neutropenic fever in high-risk patients (PIPPIN): A multicentre, open-label, phase 3, randomised, controlled trial","volume":"9","author":"Douglas","year":"2022","journal-title":"Lancet Haematol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41375-019-0547-0","article-title":"Specific gut microbiota changes heralding bloodstream infection and neutropenic fever during intensive chemotherapy","volume":"34","author":"Rashidi","year":"2020","journal-title":"Leukemia"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Wang, Y.M., Abdullah, S., Luebbering, N., Langenberg, L., Duell, A., Lake, K., Lane, A., Hils, B., Silva, O.V., and Trapp, M. (2023). Intestinal permeability of stem cell transplant patients correlates with systemic acute phase responses and dysbiosis. Blood Adv., in press.","DOI":"10.1182\/bloodadvances.2023009960"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/nri2653","article-title":"Intestinal mucosal barrier function in health and disease","volume":"9","author":"Turner","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-immunol-032712-100008","article-title":"Immunogenic Cell Death in Cancer Therapy","volume":"31","author":"Kroemer","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nri2707","article-title":"Toll-like receptor signalling in the intestinal epithelium: How bacterial recognition shapes intestinal function","volume":"10","author":"Abreu","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1086\/317513","article-title":"Circulating Cytokines as Mediators of Fever","volume":"31","author":"Netea","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1056\/NEJMoa040125","article-title":"Palifermin for Oral Mucositis after Intensive Therapy for Hematologic Cancers","volume":"351","author":"Spielberger","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0140-6736(03)12322-7","article-title":"Recombinant human interleukin 11 and bacterial infection in patients with [correction of] haematological malignant disease undergoing chemotherapy: A double-blind placebo-controlled randomised trial","volume":"361","author":"Ellis","year":"2003","journal-title":"Lancet"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Alsulami, F.J., and Shaheed, S.U. (2022). Oral cryotherapy for management of chemotherapy-induced oral mucositis in haematopoietic cell transplantation: A systematic review. BMC Cancer, 22.","DOI":"10.1186\/s12885-022-09539-8"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/bmt.2016.207","article-title":"Cryotherapy reduces oral mucositis and febrile episodes in myeloma patients treated with high-dose melphalan and autologous stem cell transplant: A prospective, randomized study","volume":"52","author":"Marchesi","year":"2016","journal-title":"Bone Marrow Transplant."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1182\/blood-2016-12-754994","article-title":"Targeting the interleukin-1 pathway in patients with hematological disorders","volume":"129","author":"Netea","year":"2017","journal-title":"Blood"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"E702","DOI":"10.1073\/pnas.1322691111","article-title":"Critical role for IL-1beta in DNA damage-induced mucositis","volume":"111","author":"Kanarek","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/j.ajpath.2014.03.012","article-title":"Inflammasome activation is reactive oxygen species dependent and mediates irinotecan-induced mucositis through IL-1beta and IL-18 in mice","volume":"184","author":"Arifa","year":"2014","journal-title":"Am. J. Pathol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41598-022-10700-3","article-title":"Supporting the gastrointestinal microenvironment during high-dose chemotherapy and stem cell transplantation by inhibiting IL-1 signaling with anakinra","volume":"12","author":"Wardill","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1111\/j.1572-0241.2007.01239.x","article-title":"Plasma citrulline concentration: A reliable marker of small bowel absorptive capacity independent of intestinal inflammation","volume":"102","author":"Papadia","year":"2007","journal-title":"Am. J. Gastroenterol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/bcpt.13851","article-title":"Anakinra and dexamethasone treatment of idarubicin-induced mucositis and diarrhoea in rats","volume":"132","author":"Kullenberg","year":"2023","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1186\/s13063-020-04847-5","article-title":"Anakinra: Efficacy in the management of fever during neutropenia and mucositis in autologous stem cell transplantation (AFFECT-2)-study protocol for a multicenter randomized double-blind placebo-controlled trial","volume":"21","author":"Biemond","year":"2020","journal-title":"Trials"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.immuni.2008.03.005","article-title":"Cytokines as Therapeutic Targets: Advances and Limitations","volume":"28","author":"Scheinecker","year":"2008","journal-title":"Immunity"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.1007\/s00520-020-05579-7","article-title":"Prediction of mucositis risk secondary to cancer therapy: A systematic review of current evidence and call to action","volume":"28","author":"Wardill","year":"2020","journal-title":"Support. Care Cancer"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cmi.2022.08.007","article-title":"Shorter antibiotic courses in the immunocompromised: The impossible dream?","volume":"29","author":"Imlay","year":"2022","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"e573","DOI":"10.1016\/S2352-3026(17)30211-9","article-title":"Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): An open-label, randomised, controlled phase 4 trial","volume":"4","author":"Espigado","year":"2017","journal-title":"Lancet Haematol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1093\/jac\/dkac190","article-title":"Safety and risk of febrile recurrence after early antibiotic discontinuation in high-risk neutropenic patients with haematological malignancies: A multicentre observational study","volume":"77","author":"Paret","year":"2022","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"e563","DOI":"10.1016\/S2352-3026(22)00145-4","article-title":"Short versus extended treatment with a carbapenem in patients with high-risk fever of unknown origin during neutropenia: A non-inferiority, open-label, multicentre, randomised trial","volume":"9","author":"Sikkens","year":"2022","journal-title":"Lancet Haematol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s00520-023-07755-x","article-title":"Viable Bifidobacterium tablets for the prevention of chemotherapy-\/radiation-induced mucositis in patients undergoing haematopoietic stem cell transplantation","volume":"31","author":"Guo","year":"2023","journal-title":"Support Care Cancer"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"eabo3445","DOI":"10.1126\/scitranslmed.abo3445","article-title":"Diet-derived metabolites and mucus link the gut microbiome to fever after cytotoxic cancer treatment","volume":"14","author":"Schwabkey","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1016\/j.cell.2022.09.007","article-title":"Mucus-degrading Bacteroides link carbapenems to aggravated graft-versus-host disease","volume":"185","author":"Hayase","year":"2022","journal-title":"Cell"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/s41385-022-00547-2","article-title":"Regulation of intestinal immunity by dietary fatty acids","volume":"15","author":"Qiu","year":"2022","journal-title":"Mucosal Immunol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1060607","DOI":"10.3389\/fimmu.2022.1060607","article-title":"Harnessing the small intestinal axis to resolve systemic inflammation","volume":"13","author":"Bodmer","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_125","first-page":"229","article-title":"Development of a self-limiting model of methotrexate-induced mucositis reinforces butyrate as a potential therapy","volume":"11","author":"Wehkamp","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41578-021-00279-y","article-title":"Engineering organoids","volume":"6","author":"Hofer","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11894-018-0615-z","article-title":"Update on Bile Acid Malabsorption: Finally Ready for Prime Time?","volume":"20","author":"Vijayvargiya","year":"2018","journal-title":"Curr. Gastroenterol. Rep."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"687627","DOI":"10.3389\/fimmu.2021.687627","article-title":"Tissue Damage in Radiation-Induced Oral Mucositis Is Mitigated by IL-17 Receptor Signaling","volume":"12","author":"Dillon","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00280-022-04463-x","article-title":"Effects of a novel toll-like receptor 4 antagonist IAXO-102 in a murine model of chemotherapy-induced gastrointestinal toxicity","volume":"90","author":"Tam","year":"2022","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1002\/jcp.30068","article-title":"Glucagon-like peptide 2 attenuates intestinal mucosal barrier injury through the MLCK\/pMLC signaling pathway in a piglet model","volume":"236","author":"Chang","year":"2021","journal-title":"J. Cell. Physiol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejca.2021.05.015","article-title":"Antibiotic-induced disruption of the microbiome exacerbates chemotherapy-induced diarrhoea and can be mitigated with autologous faecal microbiota transplantation","volume":"153","author":"Wardill","year":"2021","journal-title":"Eur. J. Cancer"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1056\/NEJMe1913807","article-title":"Fecal Microbiota Transplantation for Dysbiosis\u2014Predictable Risks","volume":"381","author":"Blaser","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/SPC.0000000000000600","article-title":"Using real world data to advance the provision of supportive cancer care: Mucositis as a case study","volume":"16","author":"Wardill","year":"2022","journal-title":"Curr. Opin. Support. Palliat. Care"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/11\/9592\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:46:35Z","timestamp":1760125595000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/11\/9592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,31]]},"references-count":133,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["ijms24119592"],"URL":"https:\/\/doi.org\/10.3390\/ijms24119592","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,31]]}}}